Metformin is associated with higher relative abundance of mucin-degrading akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut

Diabetes Care

Volumn 40, Issue 1, 2017, Pages 54-62

  De La Cuesta Zuluaga, Jacobo ^a   Mueller, Noel T ^b   Corrales Agudelo, Vanessa ^a   Velásquez Mejía, Eliana P ^a   Carmona, Jenny A ^c   Abad, José M ^d   Escobar, Juan S ^a  

^a Grupo Empresarial Nutresa   (Colombia)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Dinámica I P S dEspecialista en Ayudas Diagnósticas   (Colombia)

^d EPS y Medicina Prepagada Suramericana SA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; METFORMIN; MUCIN; SHORT CHAIN FATTY ACID; ANTIDIABETIC AGENT; RNA 16S; VOLATILE FATTY ACID;

ADULT; AKKERMANSIA MUCINIPHILA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIFIDOBACTERIUM BIFIDUM; BUTYRIVIBRIO; CLINICAL ARTICLE; CLOSTRIDIACEAE; COMMUNITY LIVING; DRUG EFFECT; DRUG USE; ENTEROCOCCUS CASSELIFLAVUS; FATTY ACID SYNTHESIS; FEMALE; GLUCOSE METABOLISM; HUMAN; INTESTINE FLORA; MALE; MEGASPHAERA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVOTELLA; PROTEIN DEGRADATION; RNA SEQUENCE; ADOLESCENT; CASE CONTROL STUDY; COLOMBIA; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; FECES; GENETICS; MICROBIOLOGY; MIDDLE AGED; VERRUCOMICROBIA;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; COLOMBIA; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, VOLATILE; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; MUCINS; RNA, RIBOSOMAL, 16S; VERRUCOMICROBIA;

EID: 85008192260     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-1324     Document Type: Article

References (40)

1. Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 2013;110:9066-9071
2. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55-60
3. Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013;498:99-103
4. Larsen N, Vogensen FK, van den Berg FWJ, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010;5:e9085
5. Zhang X, Shen D, Fang Z, et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 2013;8:e71108
6. Forslund K, Hildebrand F, Nielsen T, et al.; MetaHIT consortium. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015;528: 262-266
7. Pernicova I, Korbonits M. Metformin-mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol 2014;10:143-156
8. Lamanna C, Monami M, Marchionni N, Mannucci E. Effect of metformin on cardiovascular events and mortality: A meta-analysis of randomized clinical trials. Diabetes ObesMetab 2011;13:221-228
9. Pryor R, Cabreiro F. Repurposing metformin: an old drug with new tricks in its binding pockets. Biochem J 2015;471:307-322
10. Rena G, Pearson ER, Sakamoto K. Molecular mechanism of action of metformin: old or new insights? Diabetologia 2013;56:1898-1906
11. Lee H, Ko G. Effect of metformin on metabolic improvement and gut microbiota. Appl Environ Microbiol 2014;80:5935-5943
12. Shin N-RR, Lee J-CC, Lee H-YY, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014;63:727-735
13. Zhang X, Zhao Y, Xu J, et al. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci Rep 2015;5:14405
14. Bonora E, Cigolini M, Bosello O, et al. Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects. Curr Med Res Opin 1984;9:47-51
15. Buse JB, DeFronzo RA, Rosenstock J, et al. The primary glucose-lowering effect of metformin resides in the gut, not the circulation: Results from short-term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care 2016;39:198-205
16. Bailey CJ, Wilcock C, Scarpello JH. Metformin and the intestine. Diabetologia 2008;51: 1552-1553
17. Napolitano A, Miller S, Nicholls AW, et al. Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS One 2014;9:e100778
18. Escobar JS, Klotz B, Valdes BE, Agudelo GM. The gut microbiota of Colombians differs from that of Americans, Europeans and Asians. BMC Microbiol 2014;14:311
19. KozichJJ,WestcottSL,BaxterNT,Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol 2013;79:5112-5120
20. Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platformindependent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009;75:7537-7541
21. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2012
22. Oksanen J, Blanchet FG, Kindt R, et al. Vegan: Community Ecology Package. R package version 2.3-1, R Foundation for Statistical Computing, 2015. p. 264.
23. Chen J, Bittinger K, Charlson ES, et al. Associating microbiome composition with environmental covariates using generalized UniFrac distances. Bioinformatics 2012;28:2106-2113
24. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60
25. Storey JD, Bass AJ, Dabney A, Robinson D. qvalue: Q-value estimation for false discovery rate control. R package version 2.2.2 [Internet], 2015. Available from http://github.com/jdstorey/qvalue. Accessed 19 January 2016
26. Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011;334:105-108
27. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000;342:710-721
28. Cabreiro F, Au C, Leung KY, et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 2013; 153:228-239
29. Maida A, Lamont BJ, Cao X, Drucker DJ. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-A in mice. Diabetologia 2011;54:339-349
30. Mannucci E, Ognibene A, Cremasco F, et al. Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects. Diabetes Care 2001;24:489-494
31. Wahlström A, Sayin SI, Marschall H-U, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab 2016;24:41-50
32. Turroni F, Bottacini F, Foroni E, et al. Genome analysis of Bifidobacterium bifidumPRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad SciUSA2010;107:19514-19519
33. Sakon H, Nagai F, Morotomi M, Tanaka R. Sutterella parvirubra sp. nov. and Megamonas funiformis sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 2008;58:970-975
34. Fukuda S, Toh H, Hase K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011; 469:543-547
35. Gargari G, Taverniti V, Balzaretti S, et al. Consumption of a Bifidobacterium bifidum strain for 4 weeks modulates dominant intestinal bacterial taxa and fecal butyrate in healthy adults. Appl Environ Microbiol 2016;82:5850-5859
36. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: The role of butyrate on colonic function. Aliment Pharmacol Ther 2008;27:104-119
37. De Vadder F, Kovatcheva-Datchary P, Goncalves D, et al. Microbiota-generated metabolites promote metabolic benefits via gutbrain neural circuits. Cell 2014;156:84-96
38. Kelly CJ, Zheng L, Campbell EL, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell HostMicrobe 2015;17:662-671
39. Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014;63:1275-1283
40. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009;15:1183-1189